Milk-derived extracellular vesicles: nature’s nanocarriers for drug delivery and therapeutics
Frontiers in Pharmacology · 06.08.2025 · 16
DOI: 10.3389/fphar.2025.1595891 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 06.08.2025. Verfasst von Chen Kong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shenzhen People's Hospital, The Second Clinical Medical College, Jinan University, Shenzhen, Guangdong, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast milk-derived extracellular vesicles (MEVs) are natural nanocarriers characterized by their stability, biocompatibility, and low immunogenicity. These small, lipid bilayer-enclosed nanoparticles carry diverse bioactive molecules, including proteins, nucleic acids, and lipids, enabling them to facilitate inter-organismal communication. This review highlights the therapeutic potential of MEVs as innovative drug delivery systems, with a focus on their unique composition, functional properties, and mechanisms of action—from biogenesis and secretion to cellular uptake. We critically examine current methods for isolating and purifying MEVs, addressing challenges related to scalability, purity, cost, and standardization in industrial production. Furthermore, we discuss strategies to enhance the bioavailability and stability of MEVs for pharmaceutical applications. In conclusion, MEVs represent a scalable and cost-effective platform for therapeutic delivery, with significant potential in both nutritional and medicinal contexts. Future research should focus on optimizing production processes and advancing clinical translation to fully harness their capabilities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Shenzhen People's Hospital, The Second Clinical Medical College, Jinan University, Shenzhen, Guangdong, China.
- Department of General Medicine, Yantian District People's Hospital, Shenzhen, Guangdong, China.
- Department of Medical Administration, Huizhou Institute of Occupational Diseases Control and Prevention, Huizhou, Guangdong, China.
- Department of Emergency, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China.
- College of Rehabilitation Medicine, Jining Medical University, Jining, Shandong, China.
- Department of Rehabilitation, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China.
Zitieren
APA
Kong, C., Huang, L. B., Yang, M. F., Yue, N. N., Zhang, Y., Tian, C. M., Wang, Y. H., Wei, D. R., Shi, R. Y., Liang, Y. J., Yao, J., Wang, L. S., & Li, D. F. (2025). Milk-derived extracellular vesicles: nature’s nanocarriers for drug delivery and therapeutics. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1595891
Vancouver
Kong C, Huang LB, Yang MF, Yue NN, Zhang Y, Tian CM, et al. Milk-derived extracellular vesicles: nature’s nanocarriers for drug delivery and therapeutics. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1595891
BibTeX
@article{Kong2025,
author = {Kong, Chen and Huang, Long-Bin and Yang, Mei-Feng and Yue, Ning-Ning and Zhang, Yuan and Tian, Cheng-Mei and Wang, Yuan-Hui and Wei, Dao-Ru and Shi, Rui-Yue and Liang, Yu-Jie and Yao, Jun and Wang, Li-Sheng and Li, De-Feng},
title = {Milk-derived extracellular vesicles: nature’s nanocarriers for drug delivery and therapeutics},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1595891}
}
EUVIMED